Back

PCSK9-induced LDL receptor degradation depends on heparan sulfate proteoglycans

27 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Lipids, metabolism Lipid Metabolism, Metabolic Syndrome, Diabetes ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Simon Glerup Pedersen

Aarhus University Hospital, Aarhus (Denmark)

9 More presentations in this session

Presentation thumbnail
Doctor D. Scheiber (Duesseldorf, DE)
Abstract
Presentation thumbnail
Professor C. Saely (Feldkirch, AT)
Abstract
Presentation thumbnail
Doctor M. Elhadad (Greifswald, DE)
Abstract
Presentation thumbnail
Mrs N. Strandkjaer (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Professor C. Saely (Feldkirch, AT)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Lipids, metabolism

The Event

Event poster

ESC Congress 2018

27 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Effectiveness of PCSK9 inhibitors in homozygous familial hypercholesterolemia: insights from a Saudi Arabia genetic population
3 April 2025
thumbnail
Congress Presentation
Deletion of the asialyloglycoprotein receptor-1 (ASGR1) causes atheroprotective effects in vitro and in vivo
30 August 2024
thumbnail
Webinar
Lipid management pathways and ESC Guidelines
10 January 2023
thumbnail
Congress Presentation
Carotid plaques stabilization and regression with evolocumab
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources